We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Eczacıbaşı-Monrol Acquires US Company Capintec

By HospiMedica International staff writers
Posted on 25 Dec 2012
Eczacıbaşı-Monrol (Gebze, Turkey) has acquired Capintec (Ramsey, NJ, USA), a worldwide developer of radiation measurement and protection equipment for nuclear medicine.

Eczacıbaşı-Monrol Nuclear Products has taken a major move towards its goal of global growth by reaching an agreement to acquire Capintec, a developer of radiation measurement and protection products for nuclear medicine.

Capintec has provided sophisticated instrumentation to customers worldwide for 45 years. More...
Its innovative solutions have contributed significantly not only to nuclear medicine but also diagnostic radiology, oncology, endocrinology, and radiation therapy. Capintec’s headquarters are located in Ramsey, and its production plant in Pittsburgh (PA, USA).

Dr. Erdal Karamercan, chairman of the board of Eczacıbaşı-Monrol and president and CEO of the Eczacıbaşı Group, noted that Eczacıbaşı-Monrol took its first step towards strengthening its innovative capacity and growth potential in August 2011, when it acquired Mol-Image. “This acquisition of Capintec, the world’s best-known brand in its field,” he said, “builds on the momentum started with Mol-Image, which develops and manufactures new equipment for nuclear medicine, chemicals, radiopharmaceuticals, and radiation protection products, and represents a major advance in the achievement of our strategic global targets.”

Explaining that the advanced technology products currently manufactured by Mol-Image to US Food and Drug Administration (FDA) standards as well as related technical infrastructure and know-how would be transferred from Mol-Image to Capintec, Dr. Karamercan added, “Drawing on the synergy created by this acquisition, we will market innovative instruments and equipment developed by Capintec and Mol-Image through Eczacıbaşı-Monrol’s extensive sales and distribution channels to reach customers in Turkey, Europe and many other markets around the world.”

To demonstrate the great synergy created by the acquisition, Şükrü Bozluolçay, vice chairman of Eczacıbaşı-Monrol and chairman of the Bozlu Group, noted that Capintec would enable Eczacıbaşı-Monrol to launch its products on the American continent as well expand its product range in Europe, where it is projected there will be three production facilities and sales of EU GMP certified products in five countries by 2013.

Eczacıbaşı-Monrol Nuclear Products manufactures radiopharmaceuticals for diagnosis and treatment at world-class production centers using sophisticated and environmentally sensitive technology. Through continual investments in new technologies and production techniques, Eczacıbaşı-Monrol makes sure that its products and services are of the highest quality, meet the strictest safety standards, and comply with the latest national and international guidelines.

Eczacıbaşı-Monrol has seven production facilities in Turkey, Gebze (headquarters), Ankara, Adana, Izmir, Istanbul, Antalya, and Malatya, and four plants abroad: Romania, Egypt, Kuwait, and Dubai. With the opening of new plants in Jordan, Bulgaria, and Poland in 2013, it will have 14 plants in all.

Capintec is a world-leading supplier of energy measurement products and services focused on developing instrumentation, and services utilizing the most advanced technology. Known for its development, manufacturing, and marketing of state-of-the-art radiation measuring, monitoring and radiation protection instrumentation, Capintec supplies thousands of products as well as new systems for radiation measurement applications worldwide.

Capintec’s sales and administrative headquarters are located in Ramsey (NJ, USA) and its production facility is in Pittsburgh (PA, USA).

Related Links:
Eczacıbaşı-Monrol
Capintec



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Blood Bank Refrigerator
MBR-705GR-PE
X-Ray Meter
Cobia SENSE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.